undecylenic acid + zinc undecylenate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
undecylenic acid + zinc undecylenate: clinical details
Prescribing considerations
- Confirm the presentation is consistent with athlete’s foot; persistent or spreading disease may need diagnostic review.
- Avoid broken skin, eyes and mucous membranes.
- Consider earlier assessment for substantial pain, suspected bacterial infection, diabetes or immunosuppression.
Contraindications and cautions
- Hypersensitivity to either active ingredient or any excipient.
Monitoring
- Reconsider the diagnosis if pharmacy treatment is ineffective.
- Monitor for local irritation, contact dermatitis or hypersensitivity; discontinue if irritation is severe.
- Assess urgently if the foot becomes hot, painful and swollen.
Clinical pharmacology
Topical agents with antifungal and antibacterial properties. No usable systemic disposition data are provided for the cream; powder pharmacokinetics are listed as not applicable.
Formulation and product differences
- Cream is massaged onto affected intact skin, including between the toes.
- Powder can be applied to affected areas and inside clean socks or stockings.
- Both contain an eugenol-containing fragrance; cream also contains cetostearyl alcohol and sodium laurilsulfate.
undecylenic acid + zinc undecylenate interactions
No clinically significant medicine interactions are known for the selected products.
Other products applied to the same skin area
May increase local irritation, particularly with the cream.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.